{"id":176965,"date":"2015-08-04T00:00:00","date_gmt":"2015-08-03T22:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/plus-de-probleme-dapprovision-du-vaccin-contre-lhepatite-a-havrix-1440\/"},"modified":"2026-04-02T19:11:17","modified_gmt":"2026-04-02T17:11:17","slug":"plus-de-probleme-dapprovision-du-vaccin-contre-lhepatite-a-havrix-1440","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/plus-de-probleme-dapprovision-du-vaccin-contre-lhepatite-a-havrix-1440\/","title":{"rendered":"Plus de probl\u00e8me d\u2019approvision du vaccin contre l\u2019h\u00e9patite A Havrix 1440\u00ae"},"content":{"rendered":"<div class='tekst'>\n<p> la firme GSK a inform\u00e9 par courrier (juillet 2015) que le vaccin Havrix\u00ae est \u00e0 nouveau disponible.<\/p>\n<p> L&rsquo;approvisionnement pour Havrix Junior\u00ae est actuellement encore limit\u00e9.<\/p>\n<p> <strong>BAS initial\u00a0(janvier 2015):<\/strong><\/p>\n<p> <strong>P\u00e9nurie possible d\u2019approvisionnement des vaccins contre l\u2019h\u00e9patite A \u00a0Havrix\u00ae et Havrix Junior\u00ae (version adapt\u00e9e le 28\/07\/15)<\/strong><\/p>\n<p> La firme\u00a0 GSK pr\u00e9voit en Belgique une r\u00e9duction de la disponibilit\u00e9 des vaccins contre l\u2019h\u00e9patite A (Havrix\u00ae et Havrix Junior\u00ae)\u00a0 jusqu\u2019\u00e0 un tiers de la quantit\u00e9 normale&#x002C; et un retour \u00e0 l\u2019approvisionnement normal n\u2019est pr\u00e9vu que pour fin 2015-d\u00e9but 2016. Il en va de m\u00eame pour Havrix\u00ae de la firme Impexeco.<\/p>\n<p> Suite \u00e0 cela&#x002C; le Conseil Sup\u00e9rieur de la Sant\u00e9 a publi\u00e9 un avis concernant l\u2019utilisation la plus efficace des vaccins Havrix\u00ae et Havrix Junior\u00ae encore disponibles&#x002C; et l\u2019utilisation d\u2019autres vaccins contre l\u2019h\u00e9patite A ou des vaccins combin\u00e9s qui contiennent l\u2019h\u00e9patite A\u00a0[1]. Ainsi&#x002C; il peut \u00eatre d\u00e9cid\u00e9 par exemple de n\u2019administrer provisoirement que la premi\u00e8re dose du vaccin (une dose conf\u00e8re d\u00e9j\u00e0 plusieurs ann\u00e9es de protection) et de terminer le sch\u00e9ma de vaccination lorsque l\u2019approvisionnement sera \u00e0 nouveau normalis\u00e9. Le Conseil Sup\u00e9rieur de la Sant\u00e9 ajoute \u00e9galement entre autres que les diff\u00e9rents vaccins contre l\u2019h\u00e9patite A peuvent \u00eatre interchang\u00e9s sans probl\u00e8me (c.-\u00e0-d. Havrix\u00ae interchangeable avec Vaqta\u00ae&#x002C; et Havrix Junior\u00ae avec Vaqta Junior\u00ae).<\/p>\n<p> \u00a0<\/p>\n<p> \u00a0<\/p>\n<div>\n<hr align='left' size='1' width='33%'\/>\n<div id='ftn1'>\n<p> <a href='' name='_ftn1' title=''><br clear='all'\/> [1]<\/a>Recommandations concernant le risque de p\u00e9nurie de vaccins contre l\u2019h\u00e9patite A.\u00a0 Conseil Sup\u00e9rieur de la Sant\u00e9&#x002C; avis n\u00b0 9260&#x002C; via <a href='https:\/\/www.health.belgium.be\/internet2Prd\/groups\/public\/@public\/@shc\/documents\/ie2divers\/19100366.pdf'>www.health.belgium.be\/internet2Prd\/groups\/public\/@public\/@shc\/documents\/ie2divers\/19100366.pdf<\/a>; voir aussi communiqu\u00e9 de l\u2019AFMPS du 12\/01\/15 (via <a href='https:\/\/www.afmps.be\/'>www.afmps.be<\/a>)<\/p>\n<p> \u00a0<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>la firme GSK a inform\u00e9 par courrier (juillet 2015) que  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,178],"tags":[20213,20224],"class_list":["post-176965","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2015-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=176965"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176965\/revisions"}],"predecessor-version":[{"id":179539,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176965\/revisions\/179539"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=176965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=176965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=176965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}